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Abstract
This commentary sums the findings of a series of papers on a study that mapped the global research agenda for
maternal health. The mapping reviewed published interventional research across low— and middle-income
countries (LMICs) from 2000 to 2012, specifically focusing on investigating the topics covered by this research,
the methodologies applied, the funding landscape and trends in authorship attribution.
The overarching aim underpinning the mapping activities was to evaluate whether research and funding align with
causes of maternal mortality, and thereby highlight gaps in research priorities and governance. Fifteen reviewers
from 8 countries screened 35,078 titles and abstracts, and extracted data from 2292 full-text articles.
Over the period reviewed, the volume of publications rose several-fold, especially from 2004 to 2007. The
methodologies broadened, increasingly encompassing qualitative research and systematic review. Malaria and
HIV research dominated over other topics, while sexually-transmitted infection research progressively diminished.
Health systems and health promotion research increased rapidly, but were less frequently evaluated in trials or
published in high-impact journals. Relative to disease burden, hypertension had double the publications of
haemorrhage. Many Latin American countries, China and Russia had relatively few papers per billion US dollars
Gross Domestic Product. Total LMIC lead authorships rose substantially, but only a quarter of countries had a
local first author lead on >75% of their research, with levels lowest in sub-Saharan Africa. The median Impact
Factor of high-income country led papers was 3.1 and LMIC-led 1.8. The NIH, USAID and Gates Foundation
constituted 40% of funder acknowledgements, and addressed similar topics and countries.
The commentary notes that increases in outputs and broadening of methodologies suggest research capacity
has expanded considerably, allowing for more nuanced, systems-based and context-specific studies. However,
funders seemingly duplicate efforts, with topics and countries either receiving excessive or little attention. Better
coordinated funding might reduce duplication and allow researchers to develop highly-specialised expertise.
Repeated scrutiny of research agendas and funding may foment shifts in priorities. Building leadership capacity in
LMICs and reconsidering authorship guidelines is needed.
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Background to mapping and main findings
Progress in achieving maternal health goals and reducing
maternal deaths from individual conditions varies con-
siderably across low— and middle-income countries
(LMICs). Overall, considerably smaller reductions have
occurred in deaths from haemorrhage and hypertension,
than from HIV, for example. In principle, the research
agenda in each country and region should closely reflect
variations in outcomes and tackle the factors responsible
for local inequities. Setting such an agenda and marshal-
ling the resources to implement it does, however, require
strong capacity at country level, and an alignment be-
tween a country’s priorities and the interests of foreign
researchers and donors.
The MASCOT/MHSAR study (Multilateral Associ-
ation for Studying health inequalities and enhancing
North–south and South-South Cooperation; Maternal
Health and Health Systems in South Africa and Rwanda)
sought to build a clearer picture of this global research
agenda by mapping interventional research in maternal
health across LMICs from 2000 to 2012. It summed the
topics covered, research methodologies applied, research
funding landscape and the trends in authorship attribution
between LMIC and high-income country (HIC) re-
searchers. The study contrasted patterns in health systems
and health promotion research with those in research on
clinical conditions, specifically haemorrhage, hypertension,
malaria, HIV and other sexually transmitted infections
(STIs).
To our knowledge, this is the largest mapping of ma-
ternal health research, in terms of size, breadth of scope
and extent of international collaboration. The mapping
team involved 15 reviewers, drawn from 8 countries
across 5 continents. Together they screened 35,078 titles
and abstracts independently in duplicate, then assessed
4175 full text articles for eligibility, and extracted data
from 2292 papers on 17 variables. The LMIC study was
complemented by a mapping of literature on community-
based interventions on maternal health in HICs, which lo-
cated 119 studies on the topic. This commentary focuses
on the LMIC study, but draws a few comparisons between
the findings of the LMIC and HIC mappings. The study
procedures in both mappings, similar to a ‘scoping review’,
did not involve an evaluation of the quality of the included
studies, or the extraction of data on the outcomes of inter-
ventions. It thus synthesizes a body of literature, as op-
posed to an evaluation of literature, as in a systematic
review.
In this commentary, we sum the findings of the series
of articles on the LMIC mapping and some implications
thereof. Over the twelve years reviewed, the total num-
ber of publications in this field rose several-fold, with
the largest rise occurring from 2004 to 2007. The range
of research methods also broadened considerably, and
increasingly encompassed the application of qualitative
research and systematic review. Overall, articles on mal-
aria and HIV dominated the field, with hypertension,
haemorrhage and STI research making up less than a
third of all papers on the clinical conditions. Most espe-
cially, in several parts of sub-Saharan Africa, a very high
proportion of research addressed HIV. For example, in
Cote d’Ivoire, almost 95% of studies in this period ad-
dressed HIV. Similarly, only 1 in 30 publications in South
Africa was on haemorrhage in pregnancy. HIV research
was two-fold more likely to apply qualitative methods
than other clinical conditions, but, as compared to
haemorrhage research, it was half as likely to include a
health systems component in the intervention being
studied. The number of publications per 1000 maternal
deaths from hypertension was almost double that of
haemorrhage.
Scant attention was placed on research about equity in
the LMIC review. By contrast, the mapping of health
promotion in HICs found that a third of studies targeted
vulnerable groups, such as poor women, adolescents,
and black and ethnic minorities. The timing of interven-
tions studied also varied between LMICs and HICs. Two
thirds of the HIC studies focused on the postpartum
period, mostly addressing breastfeeding assistance and
promotion, preventing and treating post-natal depression,
or interventions to support and build capacity around par-
enting and child care. By contrast, 70% of LMIC studies
addressed issues relating to women during pregnancy and
much fewer included postpartum women.
Health system and health promotion articles increased
over the review period at a faster rate than those on
other topics, but were less likely to be evaluated in a
trial, summarised in a systematic review, or published in
high-impact journals. Studies in South Asia had a sub-
stantially greater focus on health systems or health pro-
motion research than other regions. Research on STIs
other than HIV, however, progressively diminished over
time. The number of studies on STIs, malaria, hyperten-
sion and haemorrhage were very similar in 2000–2003,
but diverged markedly thereafter. Merely 3.5% of studies
addressed STIs in 2008–2012, and many of these were
reviews, rather than empirical research.
In about ten countries, maternal health interventional
research made up more than five percent of all health
publications in the country. By contrast, in nearly twenty
other countries, studies on maternal health contributed
less than one percent to the overall research done in the
country. In India, of note, maternal health research
formed only 0.25% of all health publications from the
country and there were only 0.13 publications per billion
USD GDP. Many countries in Latin America and several
large countries like China and Russia also had very few
papers per billion USD GDP.
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In terms of funding sources, the National Institute of
Health, the US Agency for International Development,
and the Bill and Melinda Gates Foundation together made
up 40% of funder acknowledgements. For all types of fun-
ders, but especially for Global Health Initiatives, the most
common topic studied was HIV and the most common re-
gion supported was sub-Saharan Africa. Few studies were
funded by national governments, though this has slightly
risen over time. Importantly, the two main causes of ma-
ternal mortality — haemorrhage and hypertension — had
a high proportion of papers without any funder mention,
as did STI articles. This suggests that researchers have
continued their work in these critical areas, even in the ab-
sence of adequate support from funders. Funding patterns
are quite different within HICs, where national govern-
ments were the largest funding source in the papers
reviewed, followed by not-for-profit organisations.
The number of LMIC lead authorships, used as a
measure of research capacity, rose substantially in the
mid-2000s, but slowed thereafter. Findings on data own-
ership and a country’s ability to advance its own research
agenda (as measured as the proportion of articles led by
authors affiliated with an LMIC institution) were con-
cerning. Only about half the papers across the review
period were led by an LMIC author, with a further 8%
having a dual HIC and LMIC affiliation. And, only a
quarter of countries led more than 75% of their research,
while another quarter led less than 25%. Very few countries
increased the proportion of articles led over time; in some
it even decreased.
Authors affiliated with institutions in the United States
and United Kingdom together accounted for a third of
all publications. Authors from these two countries were
four times less likely than those from institutions in
mainland Europe to also hold an affiliation in a LMIC.
Of note, few authors held affiliations in more than one
LMIC. Two thirds of studies funded by USAID and the
European Union were led by HIC researchers, twice as
many as that of Wellcome Trust and Rockefeller Founda-
tion. Even in studies acknowledging funding by national
governments in LMICs, only about 70% had an LMIC lead.
Strikingly, the median Impact Factor was 3 · 1 for papers
led by a HIC author and 1 · 8 for those from LMICs. In fact,
HIC researchers lead two thirds of articles in journals with
an Impact Factor above 5, and even higher proportions of
systematic review and modelling studies. Sub-Saharan
Africa had the lowest overall proportion of locally-led
publications of all geographical regions.
Conclusions and implications of the findings
The large rise in total research outputs and broadening
of the range of methods employed over the twelve year
period reviewed indicates a major expansion in the num-
ber of researchers studying maternal health and in the
diversity of their skill sets. The apparent maturation of
maternal health research in LMICs, accompanied by an
expansion of subtlety and scope, potentially allows for
an increasingly nuanced approach to addressing research
questions. The rapid rise in health systems, health promo-
tion and qualitative research also likely reflects a cognisance
that context, social dimensions and systems determine the
effectiveness of health interventions. These factors, if
aligned with information needs and funding, bode well for
the future of maternal health research. A number of con-
cerns in the current state of maternal health research re-
main, however. Below we detail some of these concerns
and suggest ways in which they might be addressed.
The mapping findings strongly call for higher funding
levels for maternal health in general, and that such fund-
ing better reflects the distribution of maternal ill health
and the causes thereof. Allocations for a number of ma-
ternal health conditions are dwarfed by funding for HIV
research. Additional resources are especially needed
for research on haemorrhage and hypertension in sub-
Saharan Africa; but also for South Asian countries and
for other STIs worldwide. The neglect of STI research
is especially concerning given the considerable burden
of these infections and the global efforts to eliminate
mother-to-child transmission of syphilis. Maternal health
is accorded high priority by global and national policy
makers and donors, a fact that portends well for efforts to
garner additional funding. Translating these sentiments
into funding, however, will require measures to convince
governments, philanthropic agencies and other donors of
what could be achieved, and incentives for pharmaceutical
investment.
Currently, a few major funders dominate the field,
and they address similar topics and geographical areas.
Almost certainly this results in duplication of efforts,
and diffuses the focus of funders and researchers, who
develop a broad knowledge of several topics, rather
than an in-depth understanding of a few. Clearly it is
necessary to have some researchers with a broad under-
standing of a research field, but equally there are bene-
fits to having experts with more focused specialised
expertise. Moreover, particular topics and countries then
either receive concerted attention from the large funders,
or get little or no attention at all. Conditions that are
accorded low priority, such as STIs, have few alternative
funding sources, and the progression of knowledge on
these topics stagnates.
An alternative approach is worth considering. This
would involve a coordinated effort to develop a long-term,
carefully planned, progressive accumulation of knowledge
on a topic, produced by teams of funders and researchers
who steadily acquire the specialised skills required for sys-
tematically advancing a topic. Key funders would then
each take responsibility for research on certain topics and
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regions, and develop specialised expertise both within
their organisation and in research teams. This level of
coordination would necessitate sharing of information
between funders, and joint priority setting, planning
and action. Practically, coordination would encompass
the prioritisation of maternal health research topics, redir-
ection of research funding and the systematic addressing
of research capacity gaps. The finding that few authors in
LMICs hold affiliations in another LMIC suggests that
interaction and thus coordination between researchers in
different LMICs is weak. Indeed, an agenda driven by re-
searchers across LMICs seems a far-.off goal in the current
context where HIC researchers appear to dominate the
terms of collaboration. A Global Health Initiative for
maternal health, similar to those for HIV and malaria
for example, could go a long way towards coordinating
the research agenda and re-directing funding. It might
overcome market failures in technologies and drugs for
maternal health, as has been done for conditions such
as HIV and malaria. To be successful, however, this
would have to fairly represent the interests of all those
involved in this field.
Stronger research leadership in LMICs might go a long
way towards addressing many of the concerns raised
here. The mapping identified that the high levels of HIC
authorship have persisted over time, signalling deficits in
local ownership of data, as well as in internal capacity to
analyse and articulate research findings. To redress this,
research funding might include more mentorship and
specific funded opportunities for developing research
ideas, analysing data and completing publications. Too
often, money is only provided to LMIC researchers for
the technical tasks of research, such as running research
sites, and recruiting and retaining study participants.
These tasks consume the energies of local researchers,
and are not accorded value in authorship guidelines.
The dominance of HIC authors on studies supported
by some funders might indicate important variations in
expectations of authorship, and discrepancies in how
researchers and funders understand the concept of
partnership. International guidelines on authorship are
seemingly not applied uniformly. Journals themselves also
have a role to play in placing LMIC and HIC researchers
on a more equal footing. As part of article processing fees,
journals could, for example, provide more statistical and
editing assistance and give constructive feedback on ways
to improve these aspects of a paper prior to peer review. It
also seems that journals accord less value to health sys-
tems research, which, even if of good quality, is less likely
to be published in high-impact journals than clinical
studies.
Gaps in systematic review expertise in LMICs are es-
pecially concerning, given the importance of these skills
for evaluating and synthesizing locally-relevant evidence
to inform policy decisions. Also, the near absence of
health systems, health promotion and qualitative research
on some conditions might suggest that research on these
conditions still tends to adopt an over-medicalised ap-
proach. It is important, however, to note that identifying a
research gap does not necessarily signal a dissonance be-
tween the knowledge needs and the research done. Know-
ledge needs vary between fields, and differences in number
of studies and in their design might be appropriate. Imple-
mentation scale-up, supported by health systems evidence,
for example, might be the present priority in a field.
This perhaps partly explains why many of the studies
on haemorrhage included a health systems component
and interventions were evaluated in a trial.
Tracking whether the burden of different conditions
matches the research funding and outputs in different
settings, and the level of inter-funder coordination, might
promote accountability and advances in research govern-
ance. Research governance also includes documenting the
influence of funders and researchers from HICs on research
processes and authorship attribution. Standardising the
reporting of funder roles, the types of funding provided and
the support given for local research capacity and author-
ship, would promote transparency about funders’ con-
tributions, improve understanding of how funders and
researchers interact, and incentivise improvements in
these areas. In future, much of this monitoring could
be done using text mining techniques, considerably re-
ducing the effort and time taken by mapping studies
such as this one.
Lastly, it is worth noting that funding and research
priorities are likely to shift in the era of the Sustainable
Development Goals. These changes will potentially
strengthen proponents of research that specifically ad-
dresses gaps in health outcomes between populations
and between conditions. Potentially, the representation
of the major causes of maternal mortality, such as
haemorrhage, could rise substantially. Taking advantage
of opportunities in this new era will, however, require a
carefully crafted research agenda reflecting knowledge
needs and proactive steps to shift research funding.
Ongoing scrutiny of research funding distribution and
of donor coordination is warranted, alongside efforts to
address the specific capacity and leadership constraints
in different settings. Specifically, more stringent author-
ship oversight and reconsideration of authorship guide-
lines could accelerate the growth in LMIC leadership
and counter some of the inequities between LMIC re-
searchers and their more prominent HIC counterparts.
Against the background of a strategic repositioning of
maternal health within the Sustainable Development
Goals, such measures to re-align the global research
agenda might just usher in a brighter era for maternal
health.
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Box 1: Summary recommendations drawn from findings of the MASCOT MH-SAR mapping
Strategically reposition maternal health within the Sustainable Development Goals, especially concerning the potential for research
on health systems, health promotion and conditions such as haemorrhage to reduce the differential health outcomes between
population groups.
Advocate for funding to better reflect the distribution of maternal ill health and the causes thereof, with more attention given to
haemorrhage and hypertension research in sub-Saharan Africa, to research in South Asian countries in general and to studies on STIs
worldwide.
Establish a Global Health Initiative for maternal health, similar to those for HIV and malaria, which coordinates the research agenda and
funding thereof.
Translate the high priority given to maternal health by policy makers and donors into increased research funding, by convincing them of
what could be achieved with increased resources.
Apply the considerably increased extent and diversity of research capacity in LMICs to address locally-relevant research questions and to
extend the gains made in health systems and health promotion research.
Optimise funder coordination, with information sharing, joint priority setting, redirection of research resources and each funder taking
responsibility for advancing knowledge on certain topics and regions so as to avoid duplication of efforts.
Develop a long-term coordinated research strategy that allows for teams of researchers and funders to accrue specialised skills and
systematically advance knowledge on a topic.
Strengthen research leadership in LMICs by, for example, including more funded opportunities for developing research ideas, analysing
data and completing publications.
Include considerations specific to LMIC-HIC research partnerships within international authorship guidelines, such as according value to
the technical tasks of research in LMICs (running research sites, and recruiting and retaining participants).
As part of research governance, track authorship practices of different funders and HIC research institutions, aiming to understand
reasons for discrepancies in authorship attribution, and how these might be rectified.
Journals play a larger role in building research leadership in LMICs, by, for example, using part of article processing fees to provide
editing and statistical assistance, and advice on improving articles prior to peer review.
Within declaration made on journal articles about research funders, require funders to report on their support given for local research
capacity and authorship within the study concerned, if any.
Ongoing monitoring, based around text mining techniques to cover: the research topics addressed and whether these match the
burden of maternal health conditions; research methodologies applied; research funding and outputs in different settings; and the
influence of funders and researchers from HICs on authorship attribution authorship patterns between settings and funders.
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